The article concludes “Besides topical and systemic therapy, UVA1 radiation is a good option of treatment in various skin diseases. It is one of the first-line treatments for several sclerotic diseases and it often improves pruritus considerably.”
I came across this study during an internet search when a customer called me about the use of UVA1. I have to admit I was surprise by the fact that the use of UVA1 has shown some good results with atopic eczema, scleroderma and other challenges.
The authors say
“Good therapeutic effects of UVA1 therapy were shown in patients with atopic eczema, scleroderma, lichen sclerosus et atrophicus, keratosis lichenoides chronica, prurigo nodularis and with cutaneous T-cell lymphoma. Positive effects in some patients were seen in the urticaria pigmentosa and granuloma annulare group, no change to slight improvement was seen in most of the patients with rare, sclerosing skin diseases and no effect was seen in the chronic urticaria group.”The study is titled “Efficacy of UVA1 phototherapy in 230 patients with various skin diseases” and is written by S. Rombold, K. Lobisch, K. Katzer, T. C. Grazziotin, J. Ring & B. Eberlein of the Department of Dermatology and Allergy Biederstein, Technical University of Munich, Munich, Germany.
To see the entire article << CLICK HERE FOR PDF >>
UVA1 id long wavelength UV in the 340 nm to 400 nm range. UVA1 therapy has been available since the early eighties in Europe and we’re slowly catching up here in the USA. UVA1 phototherapy can be effective in the treatment of inflammatory skin diseases such as exacerbated atopic eczema, localized scleroderma and granuloma annulare.
To see the entire article << CLICK HERE FOR PDF >>